Urology Times Journal Prostate Cancer Bladder Cancer OAB and Incontinence SUO Annual Meeting Around the Practice: January 2021 Virtual Tumor Board AUA Conference BPH Evolving Treatment Approaches Perspectives in mCRPC The Latest in Testosterone Replacement Therapy

Urology Times JournalProstate CancerBladder CancerOAB and IncontinenceSUO Annual MeetingAround the Practice: January 2021 Virtual Tumor BoardAUA ConferenceBPHEvolving Treatment ApproachesPerspectives in mCRPCThe Latest in Testosterone Replacement Therapy

Opinion

Blogs Residents Lounge

BlogsResidents Lounge

Business

View More Health IT Health Law & Policy Malpractice Consult Personal Finance Practice Management

Health ITHealth Law & PolicyMalpractice ConsultPersonal FinancePractice Management

News

Clinical

All Clinical Benign Conditions Bladder Cancer BPH Challenging Anatomy Drug Therapy Female Urology Genitourinary Cancers Kidney Cancer Kidney Stones Men's Health Pediatrics Prostate Cancer Sexual Dysfunction Urologic Surgery

All ClinicalBenign ConditionsBladder CancerBPHChallenging AnatomyDrug TherapyFemale UrologyGenitourinary CancersKidney CancerKidney StonesMen's HealthPediatricsProstate CancerSexual DysfunctionUrologic Surgery

Media

Podcasts 'Y'tube K-Cast UTv Videos Around the Practice BPH Videos Medical World News Readout 360 Viewpoints

Podcasts'Y'tubeK-CastUTv VideosAround the PracticeBPH VideosMedical World NewsReadout 360Viewpoints

Conferences

Publications

Urologists in Cancer Care Urology Times Journal

Urologists in Cancer CareUrology Times Journal

Events

Live Events Virtual Events

Live EventsVirtual Events

CME/CE

Resources

Interactive Tools Job Board Sponsored

Interactive ToolsJob BoardSponsored

eNewsletter Print Subscription

eNewsletterPrint Subscription

Advertise
Contact Us
Job Board
Terms and Conditions
Privacy
Do not sell my Personnal Information

Spotlight

Urology Times Journal
Prostate Cancer
Bladder Cancer
OAB and Incontinence
SUO Annual Meeting
Around the Practice: January 2021 Virtual Tumor Board
AUA Conference
BPH
Evolving Treatment Approaches
Perspectives in mCRPC
The Latest in Testosterone Replacement Therapy

Opinion

Blogs
Residents Lounge

BusinessSee All >

Health IT
Health Law & Policy
Malpractice Consult
Personal Finance
Practice Management

Advertise
Contact Us
Job Board
Terms and Conditions
Privacy
Do not sell my Personnal Information

Adjuvant IL-2 offers survival benefit in metastatic RCC

September 1, 2002

Andrew Bowser

Orlando, FL-In patients with metastatic renal cell carcinoma, adjuvant interleukin-2 (IL-2) after cytoreductive nephrectomy appears to offer a superior survival benefit over nephrectomy followed by interferon alpha-2b, according to a report presented here at the American Society of Clinical Oncology annual meeting.